experience

Autor: Bekoz, H, Karadurmus, N, Paydas, S, Turker, A, Toptas, T, Tuglular, TF, Sonmez, M, Gulbas, Z, Tekgunduz, E, Kaya, AH, Ozbalak, M, Tastemir, N, Kaynar, L, Yildirim, R, Karadogan, I, Arat, M, Tanrikulu, FP, Ozkocaman, V, Abali, H, Turgut, M, Yuksel, MK, Ozcan, M, Dogu, MH, Hacioglu, SK, Barista, I, Demirkaya, M, Koseoglu, FD, Toprak, SK, Yilmaz, M, Demirkurek, HC, Demirkol, O, Ferhanoglu, B

Background: Reed-Sternberg cells of classical Hodgkin's lymphoma (cHL) are characterized by genetic alterations at the 9p24.1 locus, leading to over-expression of programmed death-ligand 1 and 2. In a phase 1b study, nivolumab, a PD-1-blocking antibo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::41a93b1efc07a4e851ef608091a28bf9
http://acikerisim.pau.edu.tr:8080/xmlui/handle/11499/15718

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience.

Autor: Bekoz H; Division of Hematology, Department of Internal Medicine, Medipol University, Istanbul, Istanbul, Turkey., Ozbalak M; Division of Hematology, Department of Internal Medicine, Istanbul University Istanbul Medical Faculty, Istanbul, Turkey., Karadurmus N; Division of Medical Oncology, Department of Internal Medicine, Gulhane Research and Training Hospital, Ankara, Turkey., Paydas S; Division of Medical Oncology, Department of Internal Medicine, Cukurova University, Adana, Turkey., Turker A; Division of Medical Oncology, Department of Internal Medicine, Hacettepe University, Ankara, Turkey., Toptas T; Division of Hematology, Department of Internal Medicine, Marmara University, Istanbul, Turkey., Tuglular TF; Division of Hematology, Department of Internal Medicine, Marmara University, Istanbul, Turkey., Altuntas F; Division of Hematology, Dr. Abdurrahman Yurtaslan Ankara Oncology Research and Training Hospital, Ankara, Turkey., Cakar MK; Division of Hematology, Dr. Abdurrahman Yurtaslan Ankara Oncology Research and Training Hospital, Ankara, Turkey., Sonmez M; Division of Hematology, Department of Internal Medicine, Karadeniz Technical University, Trabzon, Turkey., Gulbas Z; Division of Hematology, Anadolu Medical Center, Izmıt, Turkey., Demir N; Division of Hematology, Department of Internal Medicine, Gazi Yasargil Research and Training Hospital, Diyarbakir, Turkey., Kaynar L; Division of Hematology, Department of Internal Medicine, Erciyes University, Kayseri, Turkey., Yildirim R; Division of Hematology, Department of Internal Medicine, Ataturk University, Erzurum, Turkey., Karadogan I; Division of Hematology, Medstar Antalya Hospital, Antalya, Turkey., Arat M; Division of Hematology, Florence Nighthingale Hospital, Istanbul, Turkey., Kapucu I; Department of Internal Medicine, Koc University School of Medicine, Istanbul, Turkey., Aslan NA; Division of Hematology, Dr. Ersin Arslan Research and Training Center, Gaziantep, Turkey., Ozkocaman V; Division of Hematology, Department of Internal Medicine, Uludag University, Bursa, Turkey., Turgut M; Division of Hematology, Department of Internal Medicine, Ondokuz Mayıs University, Samsun, Turkey., Yuksel MK; Division of Hematology, Department of Internal Medicine, Ankara University, Ankara, Turkey., Ozcan M; Division of Hematology, Department of Internal Medicine, Ankara University, Ankara, Turkey., Hacioglu SK; Division of Hematology, Department of Internal Medicine, Pamukkale University, Denizli, Turkey., Barista I; Division of Medical Oncology, Department of Internal Medicine, Hacettepe University, Ankara, Turkey., Demirkaya M; Division of Medical Oncology, Department of Pediatrics, Uludag University, Bursa, Turkey., Saydam G; Division of Hematology, Department of Internal Medicine, Ege University, Izmir, Turkey., Toprak SK; Division of Hematology, Department of Internal Medicine, Ankara University, Ankara, Turkey., Yilmaz M; Division of Hematology, Department of Internal Medicine, Gaziantep University, Gaziantep, Turkey., Demirkol O; Department of Nuclear Medicine, Koc University School of Medicine, İstanbul, Turkey., Ferhanoglu B; Division of Hematology, Department of Internal Medicine, Koc University School of Medicine and V.K.V. American Hospital, İstanbul, Turkey. bferhan@gmail.com.

Publikováno v: Annals of hematology [Ann Hematol] 2020 Nov; Vol. 99 (11), pp. 2565-2576. Date of Electronic Publication: 2020 Jun 07.

Azacitidine versus decitabine in patients with refractory anemia with excess blast-Results of multicenter study.

Autor: Salim O; Akdeniz University, School of Medicine, Department of Hematology, Antalya, Turkey. Electronic address: ozansalim@gmail.com., Toptas T; Marmara University, School of Medicine, Department of Hematology, Istanbul, Turkey., Avsar E; Akdeniz University, School of Medicine, Department of Hematology, Antalya, Turkey., Yucel OK; Akdeniz University, School of Medicine, Department of Hematology, Antalya, Turkey., Ozturk E; Koc University, School of Medicine, Department of Hematology, Istanbul, Turkey., Ferhanoglu B; Koc University, School of Medicine, Department of Hematology, Istanbul, Turkey., Geduk A; Kocaeli University, School of Medicine, Department of Hematology, Kocaeli, Turkey., Mehtap O; Kocaeli University, School of Medicine, Department of Hematology, Kocaeli, Turkey., Tombak A; Mersin University, School of Medicine, Department of Hematology, Mersin, Turkey., Tiftik EN; Mersin University, School of Medicine, Department of Hematology, Mersin, Turkey., Deveci B; Antalya Training and Research Hospital, Department of Hematology, Antalya, Turkey., Kurtoglu E; Antalya Training and Research Hospital, Department of Hematology, Antalya, Turkey., Kara O; Marmara University, School of Medicine, Department of Hematology, Istanbul, Turkey., Atagunduz IK; Marmara University, School of Medicine, Department of Hematology, Istanbul, Turkey., Tuglular TF; Marmara University, School of Medicine, Department of Hematology, Istanbul, Turkey., Undar L; Akdeniz University, School of Medicine, Department of Hematology, Antalya, Turkey.

Publikováno v: Leukemia research [Leuk Res] 2016 Jun; Vol. 45, pp. 82-9. Date of Electronic Publication: 2016 Apr 11.